Home › Posts tagged Rimonabant [Acomplia]
Blog Archives

Gefährliche Schlankheitsmittel aus dem Internet: Alarmierende Analyse-Ergebnisse

Posted on by by Posted in Behördliche Mitteilung, Gravierende Unerwünschte Nebenwirkung, Thasso Post, Theragenomische Medizin No Comments ↓

6. Juni 2011 – Neue Zahlen und  Alarmierende Analyse-Ergebnisse. Das Schweizerische Heilmittelinstitut (Swissmedic) hat heute die untenstehende Mitteilung  (im Originaltext wiedergegeben) veröffentlicht.

_________________________

Gefährliche Schlankheitsmittel aus dem Internet: neue Zahlen.

Swissmedic, das Schweizerische Heilmittelinstitut, hat 122 Proben beschlagnahmter Importe von Schlankheitsmitteln im Labor untersucht.

…

Read more ›

Tags: , , , , ,

Eine Hoffnung weniger für übergewichtige Patienten: Sistierung der Zulassung von Rimonabant [Acomplia]

Posted on by by Posted in Behördliche Mitteilung, Gravierende Unerwünschte Nebenwirkung, Marktrückzug, Thasso Post, Theragenomische Medizin No Comments ↓

Aufgrund eines Entscheids des Ausschusses für Humanarzneimittel (CHMP) der 
Europäischen Arzneimittelagentur EMA wurde die Zulassung von Rimonabant [Acomplia] in der europäischen 
Union ab 23. Oktober 2008 bis auf weiteres sistiert. In der Folge wurde die Zulassung von Rimonabant [Acomplia] auch in der Schweiz sistiert.  Rimonabant [Acomplia] war in der Schweiz seit März 2007 zugelassen als Zusatztherapie zu einer leicht hypokalorischen Diät und zu einer Bewegungstherapie für die Behandlung von adiposen Patienten (BMI  >

…

Read more ›

Tags: , , , , , , , , ,

thasso: spenden

thasso: zustände

thasso: kurzmitteilungen

thasso post: magazin

View my Flipboard Magazine.

thasso: kategorien

thasso: archive

thasso: einfacher chat

You must be a registered user to participate in this chat.

RSS random genetics

  • Study examines genetic testing in diverse young breast cancer patients over a decade January 28, 2020
    Breast cancer patients diagnosed under age 50 represent 18 percent of new invasive breast cancer cases in the United States. Compared to postmenopausal women, younger women are more likely to develop aggressive subtypes of breast cancer, have a worse prognosis with increased risk of recurrence, and have higher overall mortality. Young breast cancer patients also […]
  • Novel insight into chromosome 21 and its effect on Down syndrome January 28, 2020
    A UCL-led research team has, for the first time, identified specific regions of chromosome 21, which cause memory and decision-making problems in mice with Down syndrome, a finding that provides valuable new insight into the condition in humans.
  • Decoding sickle cell disease January 28, 2020
    When Lamarcus Jean visits the Hematology Clinic at Dana-Farber/Boston Children's Cancer and Blood Disorders Center, he makes himself right at home. The 6-year-old, whom his mom, Stephanie, describes as "wise beyond his years," has been a patient here since he was born.
  • Gender differences in autism January 28, 2020
    Tools used for screening autism may play a part in the failure to detect autism in girls and women, researchers at Bournemouth University have found.
  • New gene correction therapy for Duchenne muscular dystrophy January 28, 2020
    Duchenne type muscular dystrophy (DMD) is the most common hereditary muscular disease among children, leaving them wheelchair-bound before the age of 12 and reducing life expectancy. Researchers at Technical University of Munich (TUM), Ludwig Maximilian University of Munich (LMU) and the German Research Center for Environmental Health (Helmholtz Zentrum München) have developed a gene therapy […]

RSS random science

  • China health threats likely to increase due to heatwaves January 28, 2020
    The coronavirus had caused many deaths in China this month, and a new study has shown increasingly severe and frequent heatwaves could lead to serious health emergencies in future due to climate change.Study found deadly heatwaves like the one in north-east China in 2018 have already gone from being one-in-500-year events to one-in-60-year events.Persistent extreme […]
  • Stopping sperm in its tracks: latest progress in the hunt for a male contraceptive January 28, 2020
    Researchers at the University of Dundee have developed an unrivalled, fully automated robotic screening system which allows them to rapidly test the effect of drugs and other chemicals on human sperm. The research team at Dundee, led by Professor Chris Barratt and Dr Paul Andrews, are working towards finding a safe and effective male contraceptive.
  • As seen in movies, new meta-hologram can be used as a communication tool January 28, 2020
    Junsuk Rho and his research team developed a multiplexed meta-hologram device operating at visible light. The newly developed technique can transmit information to multiple users from different locations. This can be employed in many hologram applications such as performance, exhibitions, automobiles and more.
  • The future of hazelnuts: the economic value of subseasonal forecasts January 28, 2020
    Cold spells can bring significant costs to agribusiness. Using sub-seasonal forecasts to predict extreme events 2-6 weeks in advance can bring an economic value up to 60% to the players of the hazelnut agribusiness. The results of a research by CMCC Foundation.
  • Mouse brain region processes sound and motion at the same time January 28, 2020
    New insight on how information relating to sound and movement is processed in the brain has been published today in the open-access journal eLife.
Top